ACON.NASDAQAclarion, INC

Form 4: Aclarion Director David Neal Receives RSU Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Aclarion, Inc. director David K. Neal was granted 20,000 restricted stock units as part of the company's equity incentive plan.

Summary

  • Director David K. Neal acquired 20,000 restricted stock units (RSUs) on June 11, 2026.
  • Each RSU represents a contingent right to receive one share of Aclarion, Inc. (ACON) common stock.
  • The grant was issued at a price of $0.00 per share under the company's equity incentive plan.
  • Following this transaction, the director's total beneficial ownership is 22,502 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

  • Alignment of director interests with shareholders through equity-based compensation.
  • Retention of key leadership personnel via long-term incentive structures.

Negatives

  • Potential for future shareholder dilution upon the vesting and issuance of the underlying common stock.

Risks

  • Vesting is subject to continued service, and the value of the award is dependent on future stock performance.
  • Acceleration of vesting upon a change of control could impact future corporate governance or acquisition dynamics.

Future Outlook

The RSUs are scheduled to vest in full on June 1, 2027, provided the director remains with the company, or earlier in the event of a change of control.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard practice in the healthcare technology sector to ensure long-term alignment with corporate performance goals.

Comparison to Industry Standards

  • The use of RSU grants for board compensation is consistent with standard corporate governance practices for small-cap technology firms.
  • The one-year cliff vesting schedule is a common retention mechanism for board members in the industry.

Stakeholder Impact

  • Shareholders may experience minor dilution upon the eventual conversion of RSUs into common stock.

Next Steps

  • Vesting of the 20,000 RSUs on June 1, 2027.

Key Dates

DateDescription
06/11/2026Date of RSU grant transaction.
06/12/2026Date of filing.
06/01/2027Vesting date for the 20,000 RSUs.

Keywords

Aclarion, ACON, Form 4, Insider Trading, Restricted Stock Units, Equity Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.